Bausch Health Companies Inc (BHC) Stock Price, Quote & News

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segm...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 514 744 6792

Website: www.bauschhealth.com

Address:

2150 St. ElzEar Boulevard West, Laval, Canada

momos Mar. 13 at 2:53 PM

$BHC hello darkness my old friend

1 · Reply

AKTN Mar. 12 at 7:28 PM

$BHC this company cannot be more fucked. Prove me wrong by bringing back Papa to fuck it up even harder. Donut fridays needs to make a comeback.

0 · Reply

BuyTheCrisis_ Mar. 12 at 6:00 PM

$BHC "turnaround of a lifetime" 🤡

2 · Reply

Bobberty Mar. 12 at 5:16 PM

$BHC and there she be, see ya later BHC. Good luck to all the longs suffering shareholders here. Hope it recovers some day for you.

0 · Reply

FU2 Mar. 12 at 4:58 PM

$BHC be interesting if they came trigger the $5 stop loss. Should bounce after that..but who knows with this P.O.

1 · Reply

Quantumup Mar. 12 at 12:08 PM

Citizens reiterated $SGMT Market Outperform; $35 and said, We continue to like SGMT's position in MASH, with the denifanstat/resmetirom combo targeting F4 MASH, which is the highest unmet need. $MDGL $IVA NVO LLY ALGS RHHBY ALGS VKTX $BHC $DRMA BFRI Here's what else Citizens had to say: https://x.com/Quantumup1/status/2032065360715784492?s=20

0 · Reply

Bobberty Mar. 11 at 2:01 PM

$BHC welp, about to be a small cap penny stock. Win some you lose some but I'll be selling for a loss if it hits that threshold. I don't invest in money losing penny stocks anymore at my delicate .

1 · Reply

Creyedr Mar. 10 at 7:05 PM

$BHC Good things happening at this place.

1 · Reply

brunoq14 Mar. 9 at 6:38 AM

$BHC The Phase 3 trial of larsucosterol for alcohol-related hepatitis began 01/29/2026. As of the most recent update there is currently one site in Dallas.

0 · Reply

Broview Mar. 7 at 2:36 AM

$BHC cut cost? Business solid

0 · Reply

Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada

Feb 19, 2026, 2:54 PM EST - 23 days ago

Bausch + Lomb Q4 Earnings Review: Still A Buy, With Some Caveats

Feb 19, 2026, 10:07 AM EST - 24 days ago

How Bausch Health's Turnaround Progressed In Q4 2025

Feb 19, 2026, 8:00 AM EST - 24 days ago

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres

Feb 18, 2026, 8:14 PM EST - 24 days ago

Bausch Health Companies Inc. (BHC) Q4 2025 Earnings Call Transcript

Feb 18, 2026, 4:05 PM EST - 24 days ago

BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

Feb 17, 2026, 7:00 AM EST - 26 days ago

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Feb 11, 2026, 8:00 AM EST - 4 weeks ago

Bausch Health Announces 2026 Gastrointestinal Health Scholars Program

Jan 23, 2026, 7:52 AM EST - 7 weeks ago

Bausch Health's brain dysfunction treatment fails late-stage trial

Jan 23, 2026, 7:45 AM EST - 7 weeks ago

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Jan 21, 2026, 7:00 AM EST - 7 weeks ago

Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026

Jan 15, 2026, 3:15 AM EST - 2 months ago

Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 5, 2026, 7:00 AM EST - 2 months ago

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 23, 2025, 5:35 PM EST - 2 months ago

Bausch Health Announces Final Results and Expiration of Exchange Offers

Dec 8, 2025, 7:22 PM EST - 3 months ago

Bausch Health Announces Early Exchange Offer Results for Exchange Offers

Dec 2, 2025, 12:43 PM EST - 3 months ago

Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 1, 2025, 7:00 AM EST - 3 months ago

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China

Nov 24, 2025, 7:05 AM EST - 3 months ago

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes

Nov 18, 2025, 7:00 AM EST - 4 months ago

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

Nov 13, 2025, 8:18 AM EST - 4 months ago

Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical

Nov 13, 2025, 7:00 AM EST - 4 months ago

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

Nov 11, 2025, 7:07 AM EST - 4 months ago

Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path

Nov 5, 2025, 8:00 AM EST - 4 months ago

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Nov 3, 2025, 4:30 PM EST - 4 months ago

Bausch + Lomb to Hold Investor Day on Nov. 13

Oct 31, 2025, 7:45 AM EDT - 4 months ago

Why Bausch Health Is A Buy After Rising 10% On Third-Quarter Results

Oct 29, 2025, 8:26 PM EDT - 4 months ago

Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:05 PM EDT - 4 months ago

Bausch Health Announces Third Quarter 2025 Results

Oct 20, 2025, 10:57 AM EDT - 5 months ago

Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Oct 9, 2025, 7:00 AM EDT - 5 months ago

Bausch Health Announces Results of Special Meeting of Shareholders

Sep 30, 2025, 8:00 AM EDT - 5 months ago

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV

Sep 30, 2025, 7:00 AM EDT - 5 months ago

Bausch Health to Announce Third Quarter 2025 Results on October 29

Sep 29, 2025, 8:00 AM EDT - 5 months ago

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

Sep 11, 2025, 12:04 PM EDT - 6 months ago

Bausch Health: Repricing Continues As Deleveraging Gains Traction

Sep 11, 2025, 8:35 AM EDT - 6 months ago

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio

Sep 11, 2025, 7:00 AM EDT - 6 months ago

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

Sep 9, 2025, 7:00 AM EDT - 6 months ago

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

Sep 5, 2025, 8:02 AM EDT - 6 months ago

Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System

Aug 26, 2025, 8:00 AM EDT - 7 months ago

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

DRRX

Aug 21, 2025, 8:02 AM EDT - 7 months ago

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan

Aug 18, 2025, 5:48 PM EDT - 7 months ago

Bausch + Lomb board members resign after Icahn agreement ends

Aug 15, 2025, 2:30 PM EDT - 7 months ago

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes

Aug 12, 2025, 1:02 PM EDT - 7 months ago

Why Bausch Health Stock Surged By Nearly 20%

Aug 7, 2025, 8:00 AM EDT - 7 months ago

Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners

Jul 30, 2025, 11:30 PM EDT - 8 months ago

Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 4:05 PM EDT - 8 months ago

Bausch Health Announces Second Quarter 2025 Results

Jul 29, 2025, 2:21 PM EDT - 8 months ago

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

DRRX

Jul 29, 2025, 7:00 AM EDT - 8 months ago

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

DRRX

Jul 29, 2025, 7:00 AM EDT - 8 months ago

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

Jul 28, 2025, 9:10 AM EDT - 8 months ago

Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand

Jul 24, 2025, 8:02 AM EDT - 8 months ago

Bausch Health Announces the Appointment of Two New Members to Its Board of Directors

momos Mar. 13 at 2:53 PM

$BHC hello darkness my old friend

1 · Reply

AKTN Mar. 12 at 7:28 PM

$BHC this company cannot be more fucked. Prove me wrong by bringing back Papa to fuck it up even harder. Donut fridays needs to make a comeback.

0 · Reply

BuyTheCrisis_ Mar. 12 at 6:00 PM

$BHC "turnaround of a lifetime" 🤡

2 · Reply

Bobberty Mar. 12 at 5:16 PM

$BHC and there she be, see ya later BHC. Good luck to all the longs suffering shareholders here. Hope it recovers some day for you.

0 · Reply

FU2 Mar. 12 at 4:58 PM

$BHC be interesting if they came trigger the $5 stop loss. Should bounce after that..but who knows with this P.O.

1 · Reply

Quantumup Mar. 12 at 12:08 PM

0 · Reply

Bobberty Mar. 11 at 2:01 PM

$BHC welp, about to be a small cap penny stock. Win some you lose some but I'll be selling for a loss if it hits that threshold. I don't invest in money losing penny stocks anymore at my delicate .

1 · Reply

Creyedr Mar. 10 at 7:05 PM

$BHC Good things happening at this place.

1 · Reply

brunoq14 Mar. 9 at 6:38 AM

$BHC The Phase 3 trial of larsucosterol for alcohol-related hepatitis began 01/29/2026. As of the most recent update there is currently one site in Dallas.

0 · Reply

Broview Mar. 7 at 2:36 AM

$BHC cut cost? Business solid

0 · Reply

FU2 Mar. 5 at 4:42 PM

$BHC feels like we are close to bottom, probably safe to load here.

0 · Reply

FU2 Mar. 5 at 3:38 PM

$BHC drop it .10 more cents and I'm a buyer again..

0 · Reply

Davidhansraj Mar. 5 at 2:56 PM

$BHC I don’t know what you mean by insiders selling off. It is one person. But this week alone someone purchased over 5 million shares where is the sell off?

0 · Reply

tregninnaw Mar. 5 at 2:32 PM

$BHC with insiders selling off some substantial shares in BHC i doubt theres any positive news coming in the near future. The pain of buying VRX when it was in the low $100's. Ive averaged down as far as i care go to.

2 · Reply

Davidhansraj Mar. 5 at 1:01 PM

$BHC there were two large purchases of over 2.5 million shares after the bell two days ago

0 · Reply

Rpate Mar. 4 at 2:41 PM

$BHC I believe insiders are selling.

1 · Reply

kbingo12 Mar. 4 at 11:59 AM

$BHC https://www.tevapharm.com/news-and-media/latest-news/teva-and-blackstone-life-sciences-announce-$400-million-strategic-growth-capital-agreement-to-advance-duv/

0 · Reply

copywrites Mar. 4 at 10:26 AM

$BHC https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhc/bausch-health-companies/news/xifaxan-win-and-bausch-plus-lomb-spinoff-plans-reframe-bausc/amp hey world, wake up !

2 · Reply

Davidhansraj Mar. 3 at 9:19 PM

$BHC do you see any large buys after the bell?

1 · Reply

copywrites Mar. 2 at 9:43 PM

$BHC 👀

0 · Reply

Broview Feb. 28 at 12:12 PM

$BHC lowering debt please?

0 · Reply

FU2 Feb. 28 at 3:08 AM

$BHC nice buy of almost 46k shares by HYOSIG. Just over doubles his position.

0 · Reply

Market Cap	1.85B
Revenue (ttm)	10.27B
Net Income (ttm)	157.00M
EPS (ttm)	N/A
PE Ratio	1.33
Forward PE	1.22
Profit Margin	1.53%
Debt to Equity Ratio	55.22

Volume	2,067,000
Avg Vol	2,351,800
Day's Range	N/A - N/A
Shares Out	372.58M
Stochastic %K	3%
Beta	0.37
Analysts	Hold
Price Target	$7.67